Egypt Dermatology Market Analysis Sample Report

Egypt Dermatology
Market Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)

This report presents a strategic analysis of the Egypt Dermatology
Market and a forecast for its development in the medium and long term. It
provides a comprehensive overview of the market value, dynamics,
segmentation, characteristics, main players, trends and insights, growth
and demand drivers, challenges & future outlook, etc. This is one of the
most comprehensive reports about the Egypt Dermatology Market, and
offers unmatched value, accuracy, and expert insights

Table of
Contents
• Market Overview
• Growth Drivers & Restraints
• Market Segmentation
• Major Market Share
• Competitive Landscape
• Key Company Profiles
• Healthcare Policies & Regulatory Framework
• Factors Driving Future Growth
• Future Opportunities
• Conclusion

4 A Sample Report on Egypt Dermatology Market Analysis I Confidential
Table of Contents
1. Egypt Dermatology Market Analysis Overview………………..……..….………………..…………………..................................07
1.1 Market size and forecast
2. Market Growth Drivers and Restraints …………………………………………………………………….…………….…………….09
2.1 Market Growth Drivers
2.1.1 Increase in prevalence of skin diseases
2.1.2 Rise in awareness among individuals regarding skin diseases
2.1.3 Increase in number of approval for dermatological products
2.2 Market Restraints
2.2.1 Availability of alternatives for acne treatment
2.2.2 Multiple risks associated with dermatology treatment
3. Major Dermatology Diseases……………………………………………………………………………………………………………..16
3.1 Acne
3.2 Dermatitis
3.3 Psoriasis
3.4 Skin cancer
3.5 Rosacea
3.6 Alopecia & others

Table of Contents (continued)
4. Market Segmentation……………………………………………………………….…………………..…………………..………….….19
4.1 By Type
4.2 By Route Of Administration
5. Major Products Market Share………………………..…………………………………………………………………..…………....…24
5.1 Major Market Share
6. Competitive Landscape……………………………………………………..……………………...…………..…................................26
6.1 Major Companies For Egypt Dermatology Market
7. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ……………………..…….......28
7.1 AbbVie Inc.
7.2 Amgen Inc.
7.3 GlaxoSmithKline PLC.
7.4 Johnson & Johnson
7.5 Novartis AG
8. Healthcare Policies and Regulatory Landscape…………………………………………………….……………………..………....39
8.1 Regulatory Framework Of Egypt Dermatology Market Analysis
8.2 Reimbursement Scenarios

Table of Contents (continued)
9. Factors Driving Future Growth………….…………………………………………………………..………………………..………....42
9.1 Recent developments in Egypt Dermatology Market Analysis
10. Conclusion……………………………..…………..………………………………….………………………………………………......44
10.1 Conclusion

Egypt Dermatology Market Analysis
1. Overview

▪ Egypt Dermatology Market stood at around $48 Mn in
2022 and is projected to reach $120 Mn by 2030,
exhibiting a CAGR of 12.3% during the forecast period
▪ Rise in prevalence of skin conditions like acne, atopic
dermatitis, skin cancer, and rosacea; rising consumer
demand for topical dermatological products; rising funding
from private and public organizations for the expansion of
pharmaceutical manufacturing segments; and rising R&D
activities for the advancement of dermatological products
are the main factors driving the Egypt dermatology
market's growth
▪ Psoriatic arthritis(PsA) was found to be 30% prevalent in
Egypt, with a mean age of 45.48 10.79 years
Key Analysis
1.1 Market Size & Forecast

2. Growth Drivers and Growth Restraints

Increase in prevalence of
skin diseases
Increase in number of
approval for dermatological
products
Availability of alternatives for acne
treatment
Impact
Impact
Market
Drivers
Market
Restraints
Rise in awareness among
individuals regarding skin
diseases
Market Growth Drivers And Restraints
Multiple risks associated with
dermatology treatment

2.1.1 Increase in prevalence of skin diseases
▪ Highest rate of prevalence applied to parasitic skin infestations (pediculosis capitis, 37.6%). Eczema or dermatitis
were found in 25.8% of population
▪ Prevalence of skin diseases has increased over the last few decades and they contribute to a significant burden
on the healthcare systems all across the country
2.1 Market Growth Drivers

Market Growth Drivers (Continued)
2.1.2 Rise in awareness among individuals regarding skin diseases
▪ NTDs include schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis, leishmaniasis, fascioliasis, and
the epidermal parasitic skin diseases
▪ Egypt has the highest rates of neglected tropical diseases(NTDs) in the Middle East and North Africa region;
these diseases are endemic in Egypt since Pharaonic time

Market Growth Drivers (Continued)
2.1.3 Increase in number of approval for dermatological products
▪ Sanofi Egypt is the first company in Africa to obtain approval from the Egyptian Drugs Authority for registering as
a treatment for atopic dermatitis

2.2 Market Restraints
2.2.1 Availability of alternatives for acne treatment
▪ One of the meditation alternatives is laser Treatment is a cosmetic procedure that uses several laser techniques
to cure common skin problems like sunburn, wrinkles, dark spots, etc
▪ Treatment of Acne depends largely on the severity and on the individual. If the acne is presented in a mild form
then over the counter gels and creams can be very effective but can still take months to clear

Market Restraints (Continued)
2.2.2 Multiple risks associated with dermatology treatment
▪ However, there are a number of potential negative effects linked to dermatology procedures. Patients undergoing
cosmetic procedures may have a number of hazards and consequences before, during, or after the surgery
▪ In last two decades, the popularity of dermatology procedures has increased

3. Major Dermatology Diseases

3. Major Dermatology Diseases
3.3 Psoriasis
3.2 Dermatitis
3.1 Acne
▪ Acne vulgaris is the most
common dermatoses affecting
adolescents with significant
impact on their quality of life
(QoL)
▪ It has a valuable impact on
quality of life among
adolescents attending
secondary schools in Egypt
▪ Atopic dermatitis (AD), a
chronic relapsing skin
condition that affects children
more frequently than adults, is
characterised by decreased
cutaneous innate immunity
and compromised skin barrier
▪ Between 10% and 12% of
Egyptian children were
thought to have AD, with
varying degrees of severity
and problems
▪ Around the world, psoriasis is
a common condition
▪ Egypt, an African nation with a
Caucasian majority, it has a
prevalence of psoriasis that
ranges from 0.19% to 3%

Major Dermatology Diseases (Continued)
3.6 Alopecia & Others
3.5 Rosacea
3.4 Skin cancer
▪ In Egypt, skin cancer is
common among elderly males
and its etiology may be related
to sun exposure
▪ Reason why males are more
likely than women to work
outside and hence have a
higher risk of developing skin
cancer is because they make
up the majority of the
workforce (outdoor labour)
▪ Rosacea is a chronic skin
condition where the skin turns
red and develops
uncomfortable blisters,
typically on the face
▪ It is impacted both men and
women equally,
predominatingly in people
between the ages of 45 and
60
▪ Androgenetic alopecia (AGA)
was the most prevalent factor
in the frontal hairline receding
in Egyptian female
patients(50%)
▪ Women under 35 were the
most afflicted, with a
prevalence of traction
alopecia(TA) of 34.5%

4. Market Segmentation

Egypt Dermatology Market Segmentation
Egypt Dermatology Market Segmentation
By Type
By Route Of
Administration

Snapshot Of Egypt Dermatology Market Analysis Segmentation
By Route Of Administration
By Type
▪ Prescription-
based drugs
▪ Over-the-counter
drugs
▪ Topical
administration
▪ Oral
administration
▪ Parenteral
administration

Prescription-based drugs Over-the-counter drugs
▪ Prescription medications, a subcategory of the
prescription mode segment, are anticipated to hold a
larger market share throughout the course of the forecast
period
▪ This would be due to the accessibility of a wide variety of
prescription medications, rising preference for
dermatologist consultations for persistent skin issues, and
rising awareness of skin diseases
4.1 Market Segmentation: By Type
Egypt Dermatology Market Share by Type
(2022)
Key Insights

▪ Egypt Dermatology Market is divided into topical, oral, and
parenteral administration routes
▪ Due to the rising demand for topical dermatological
medications such anti-inflammatory, anti-infective, local
anesthetics, cleansers, and emollients to treat acne, the
topical segment had a significant share of the market
4.2 Market Segmentation: By Route Of Administration
Egypt Dermatology Market Share by Route Of Administration
(2022)
Topical administration Oral administration Parenteral administration
Key Insights

5. Major Market Share

5.1 Egypt Dermatology Market Share
Major Market Revenue of Egypt Dermatology Market ($Bn)
(2022)
Brand 1 Brand 2 Brand 3 Brand 4 Brand 5 Other
▪ Dermatology has had and continues to experience
tremendous improvements in technology, medication, and
therapies, just like other medical specialties
▪ Dermatologists and other skin care professionals attribute a
large portion of this progress to fundamental medical
discoveries.
Key Insights

6. Competitive Landscape

6.1 Competitive Landscape: Key Players Revenue (Current and Forecasted)
Major Market Revenue of Egypt Dermatology Companies ($Bn)
2022 Key Insights
AbbVie Inc. $46.2 • SAMPLE
Amgen Inc. $26 • SAMPLE
GlaxoSmithKlin
e PLC.
$39.25 • SAMPLE
Johnson &
Johnson
$93.77 • SAMPLE
Novartis AG $51.6 • SAMPLE

7. Key Company Profiles

7.1 AbbVie Inc.
▪ AbbVie Inc (AbbVie) is a specialty biopharmaceutical
company, which discovers, develops, manufactures, and
commercializes drugs for the treatment of chronic and
complex diseases
▪ Its drugs are indicated for the treatment of metabolic
diseases, rheumatological diseases, neurological disorders,
viral diseases, skin diseases, complications associated with
cystic fibrosis, pain related to endometriosis, diseases of the
gastrointestinal tract, various types of cancer, and other
serious health conditions
Company Name: AbbVie Inc.
Year of Establishment: 2013
Headquarter: North Chicago, US
Revenue (US): $37.4 Bn (2022)
Website: www.abbvie.com
Company at a Glance
Company Overview

AbbVie Inc.
Breakdown of net revenue by segment, 2022
Revenues ($Bn), 2022-2030F
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.2 Amgen Inc.
▪ Amgen Inc (Amgen) is a biotechnology company which
discovers, develops, manufactures, and markets innovative
human therapeutics to treat patients suffering from serious
diseases
▪ It develops novel medicines in six focused therapeutic areas
including cardiovascular disease, oncology/hematology,
inflammation, bone health, neuroscience and nephrology
Company Name: Amgen Inc.
Headquarter: Cambridge, US
Revenue (US): $26 Bn (2022)
Website: www.amgen.com
Company at a Glance
Company Overview

Amgen Inc.
Analysis
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn
1 2 3 4

7.3 GlaxoSmithKline PLC.
▪ GlaxoSmithKline Pharmaceuticals Ltd (GSK), a subsidiary of
GlaxoSmithKline Plc manufactures and markets prescription
medicines and vaccines
▪ Prescription medicines include therapeutic areas such as,
analgesic, anti-infective, cardiovascular, anti-inflammatory,
diabetes, anti-parasitic, dermatology, endocrine,
gastrointestinal, gynaecology, immunosupressants, nutritional,
respiratory, central nervous system (CNS) and oncology
Company Name: GlaxoSmithKline PLC.
Headquarter: London, UK
Revenue (US): $39.25 Bn (2022)
Website: www.gsk.com
Company at a Glance
Company Overview

GlaxoSmithKline PLC.
Analysis
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn
1 2 3 4

7.4 Johnson & Johnson
▪ Johnson & Johnson (J&J) researches, develops,
manufactures, and sells pharmaceutical products, medical
devices, and consumer products
▪ Company provides pharmaceuticals for immune diseases,
cancer, neurological disorders, infectious, cardiovascular and
metabolic diseases; consumer products in oral care, baby
care, beauty, over-the-counter (OTC) medicines, women’s
health and wound care categories; and medical devices for
use in the cardiovascular, orthopaedic, general surgery and
vision care fields
Company Name: Johnson & Johnson
Headquarter: New Jersey, US
Revenue (US): $93.77 Bn (2022)
Website: www.jnj.com
Company at a Glance
Company Overview

Johnson & Johnson
Analysis
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn
1 2 3 4

7.5 Novartis AG
▪ Novartis AG (Novartis) is a healthcare company that focuses
on the discovery, development, manufacture and marketing of
prescription and generic pharmaceutical products and eye
care products
▪ It provides drugs for the treatment of cancer, cardiovascular
diseases, dermatological conditions, neurological disorders,
ophthalmic and respiratory diseases, immune disorders, and
infections, among others
Company Name: Novartis AG
Headquarter: Basel, Switzerland
Revenue (US): $51.6 Bn (2022)
Website: www.novartis.com
Company at a Glance
Company Overview

Novartis AG
Analysis
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn
1 2 3 4

8. Healthcare Policy and Regulatory Landscape

8.1 Regulatory Framework Of Egypt Dermatology Market
▪ Pharmaceutical sector in Egypt is mainly regulated by law No. 127 of 1955 on the Pharmacy Profession (“Pharmacy
Law”) and other decrees and internal circulars issued by MoH and its affiliated bodies
▪ One of the constitutional rights under the Egyptian Constitution, as amended in 2014, is the healthcare right. Part of
the healthcare right is the accessibility of medicines in an equal manner and at affordable prices
▪ Constitution mandates on the Government to spend at least 3% of the GDP on healthcare. Such percentage is
supposed to gradually increase to reach the international standards
▪ Government agency in charge of overseeing all matters pertaining to the pharmaceutical industry is the Ministry of
Health (MoH)
▪ Pharmaceutical industry is primarily overseen by three major agencies connected to the MoH:
o Central Administration of Pharmaceutical Affairs (CAPA)
o National Organization for Drugs Control and Research (NODCAR)
o National Organization for Research and Control of Biologicals (NORCB)

8.2 Reimbursement Scenarios
▪ Ministry of Health and Population (MOHP) facilities and Health Insurance Organizations follow to the MOHP-provided
reimbursement process
▪ There are other institutions or ministry-affiliated public facilities follow MOHP regulations but have their own budget
and autonomy
▪ Private sector organisations are subject to the MOHP's healthcare standards and rules, although they are exempt
from the MOHP's rules on reimbursement
▪ Tender Drugs list and reimbursement price are established by the procurement department and published and
distributed to all MOHP facilities
▪ With a reasonable budget, any hospital or primary care institution can buy their medications directly from Drugs
manufacturers or distributors at the price listed on the tender medicine list

9. Future Development Growth

9.1 Recent Developments In Egypt Dermatology Market
▪ According to the MoH, Egypt's first health map, which will incorporate all data pertaining to various ailments
depending on the outcomes of health initiatives, would be finished by March 2023
▪ After more than 60 nations with over 300,000 patients on therapy, Egypt became the first nation in Africa to approve
Dupixent for use in patients with moderate-to-severe atopic dermatitis

10. Conclusion

10.1 Conclusion
1
2
3
5
4
Strong Demand
Market for pharmaceuticals, aesthetic
lasers, and cosmetic dermatology are
all experiencing growth due to the rising
demand for aesthetic procedures
Emerging economy
Egypt’s emerging economy offer
significant growth for players operating in
dermatology market
Growing Technology Advancements
There has been a marked rise in the choice for
minimally invasive and non-invasive aesthetic
operations over traditional surgical procedures
Competition in market
Egypt will soon have significant potential
for pharmaceutical industry expansion due
to its expanding population and favorable
government regulations
Advancement in healthcare delivery
Egypt is one of the leading producers
and consumers of pharmaceuticals in
Africa and the Middle East, with over
120 domestic pharma companies

Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Primary
Research
Secondary
Research
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Data Collection
Market Data Analysis
& Statistical Model
Interpretation &
Presentation

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2022
2022-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is
currently not a part of our scope as a part of
customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

The report is prepared
using a proven
methodology and insightful
research
Reliable
The data is prepared by a
team of highly qualified &
experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to confidently
make smarter business and
strategic decisions
Real
Covers everything you
would need to know about
the market including
market size, competitive
analysis & much more
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works
Easy to read
What kind of Data is Presented
in this Report?
This report presents data, which is:
www.insights10.com

www.insights10.com
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Lifesciences Market
Research Reports you
can trust

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get Insights to take
informed Business
Decisions
www.insights10.com

Market Research Reports
across various domains of healthcare
Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices

Our
Services
1
2
3
4
5
6
10
9
8
7
Market Research Reports
Customized Reports
Primary Research
Database Services
Full-Time Engagement
Conference Coverage
Competitive Intelligence
Strategic Research Projects Regulatory Compliance
Report Subscription Services

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
www.insights10.com

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Mukesh is an engineering graduate
with an MBA in Marketing. He is a
seasoned healthcare market
research & marketing professional
with a progressive experience of over
20 years in Life Sciences, Pharma
and Medical Device sectors. With an
in-depth understanding of primary
research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare
& completed several research
projects across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Dhruv Joshi is an engineer and has done
Masters in Hospital Administration with
over 4 years of experience in the
healthcare and life science industry. He
has gained proficiency in market
research, market assessment, and
developing insights from it. He has
worked on various consulting projects
across different geographies including
Asia, Europe, US, MENA. He has been
aligned in working for sector reports of
various geographies along with market
sizing and forecasting.
Dr. Purav Gandhi
Founder & CEO
Mukesh Nayak
Head - Marketing
Ritu Baliya
Engagement Manager
Dhruv Joshi
Consultant
Project Leadership Team

7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below
… and many more

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.

Egypt Dermatology Market Analysis Sample Report

Recommended

Recommended

More Related Content

Similar to Egypt Dermatology Market Analysis Sample Report

Similar to Egypt Dermatology Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Egypt Dermatology Market Analysis Sample Report